Crosstalk between Complement and Toll-Like Receptors

被引:75
|
作者
Song, Wen-Chao [1 ,2 ]
机构
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
complement; TLR; innate immunity; inflammation; cytokines; ADAPTIVE IMMUNE-RESPONSES; HEMOLYTIC-UREMIC SYNDROME; INNATE IMMUNITY; ALTERNATIVE PATHWAY; CELL-ACTIVATION; T-CELLS; SIGNAL-TRANSDUCTION; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; DROSOPHILA TOLL;
D O I
10.1177/0192623311428478
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The complement system and toll-like receptors (TLRs) are two components of innate immunity that are critical for first-line host defense. Many pathogen-associated molecular patterns activate both complement and TLRs, and recent studies in animal models have revealed a marked synergistic interaction between the two systems. In mice deficient in a membrane complement regulator, prototypical TLR ligands such as LPS, zymosan, and polyI:C caused increased systemic complement activation, which in turn led to a profound elevation of proinflammatory cytokine biosynthesis. This phenotype required interaction between complement and TLRs because complement activation alone by cobra venom factor without TLR engagement did not lead to appreciable cytokine production. The regulatory effect of complement on TLR signaling was mediated by the anaphylatoxins C5a and C3a through a receptor-dependent mechanism and involved increased mitogen-activated protein kinase and nuclear factor kappa B activation. The crosstalk between complement and TLRs may also impact adaptive immunity, for example, the differentiation of T helper 17 (Th-17) cells. Given that excessive activation of either TLR or complement has been associated with inflammatory tissue injury as occurs in sepsis and autoimmune diseases, the new insight on complement and TLR crosstalk may have therapeutic implications.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 50 条
  • [21] Toll-like receptors
    Dasari, P.
    Nicholson, I. C.
    Zola, H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2008, 22 (01): : 17 - 26
  • [22] Toll-like receptors
    Warren, HS
    CRITICAL CARE MEDICINE, 2005, 33 (12) : S457 - S459
  • [23] Toll-Like Receptors
    Kundakci, Aycan
    Pirat, Arash
    JOURNAL OF THE TURKISH SOCIETY OF INTENSIVE CARE-TURK YOGUN BAKM DERNEGI DERGISI, 2012, 10 (02): : 63 - 73
  • [24] Toll-like receptors
    Lien, E
    Ingalls, RR
    CRITICAL CARE MEDICINE, 2002, 30 (01) : S1 - S11
  • [25] Toll-like receptors
    Muzio, M
    Mantovani, A
    MICROBES AND INFECTION, 2000, 2 (03) : 251 - 255
  • [26] A crosstalk between toll-like and Fas receptors ligands - Modulatory effect of IGF-I
    Kocic, G.
    Jevtovic, T.
    Pavlovic, D.
    Kocic, R.
    Bjelakovic, G.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S159 - S159
  • [27] Toll and Toll-like receptors in Drosophila
    Bilak, H
    Tauszig-Delamasure, S
    Imler, JL
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 648 - 651
  • [28] Taking toll of toll-like receptors
    Kreeger, KY
    SCIENTIST, 2003, 17 (09): : 34 - 35
  • [29] Interplay between complement factor B and Toll-like receptors and its role in septic cardiomyopathy
    Zou, Lin
    Li, Yan
    Feng, Yan
    Zhang, Ming
    Chen, Chan
    Chao, Wei
    FASEB JOURNAL, 2013, 27
  • [30] The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis
    Hovland, Anders
    Jonasson, Lena
    Garred, Peter
    Yndestad, Arne
    Aukrust, Pal
    Lappegard, Knut T.
    Espevik, Terje
    Mollnes, Tom E.
    ATHEROSCLEROSIS, 2015, 241 (02) : 480 - 494